TipRanks
Vir Biotechnology (MX:VIR)
:VIR
Mexico Market
VIR
Vir Biotechnology
RESEARCH TOOLSreports

Vir Biotechnology (VIR) Income Statement

4 Followers

Vir Biotechnology Income Statement

Last quarter (Q2 2026), Vir Biotechnology's total revenue was $238.95M, an increase of 19582.54% from the same quarter last year. In Q2, Vir Biotechnology's net income was $80.08M. See Vir Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 68.56M$ 74.20M$ 86.18M$ 1.62B$ 1.10B
Gross Profit
$ 56.85M$ 58.80M$ 63.96M$ 1.45B$ 1.02B
Operating Expenses
$ 524.87M$ 582.22M$ 724.97M$ 620.92M$ 602.99M
Depreciation and Amortization
$ 11.68M$ 14.56M$ 19.45M$ 15.49M$ 11.98M
EBITDA
$ -456.34M$ -508.86M$ -641.55M$ 848.56M$ 432.73M
Operating Income
$ -468.02M$ -523.42M$ -661.00M$ 833.07M$ 420.75M
Other Income/Expenses
$ 30.25M$ 316.00K$ 32.81M$ -78.79M$ 129.05M
Pretax Income
$ -437.77M$ -523.11M$ -628.19M$ 754.28M$ 549.80M
Net Income
$ -437.99M$ -521.96M$ -615.06M$ 515.84M$ 528.58M
Per Share Metrics
Basic EPS
$ -3.16$ -3.83$ -4.59$ 3.89$ 4.07
Diluted EPS
$ -3.16$ -3.83$ -4.59$ 3.83$ 3.96
Weighted Average Shares Outstanding
 138.52M 136.25M 134.13M 132.61M 129.88M
Weighted Average Shares Outstanding (Diluted)
 138.52M 136.25M 134.13M 134.81M 133.44M
Currency in USD

Vir Biotechnology Earnings and Revenue History